Answers are grounded in this paper and cite their sources.
Objective: The study examined differences in vaginal microbial profile of women with infertility and those seeking contraception in Ghana. Methodology: This multi-centered comparative cross-sectional study collected sociodemographic data, and high vaginal swabs (HVS) of women with infertility and those seeking contraception at two Centers in Accra, Ghana. HVS samples underwent microscopy, Gram-staining and culture-and-sensitivity testing using Kirby-Bauer disk diffusion technique. Patients with recent vaginal infection or antibiotic therapy were excluded. Data was analyzed using SPSS-2020. Associations between the two groups and their vaginal microbiological results were tested using multiple logistic regression and reported as odds ratios (OR). Confidence interval was set at 95%, and p-values <0.05 considered statistically significant. Results: Overall, 172 women, comprising 112 seeking fertility treatment and 60 seeking contraception, participated in the study. Following culture, 40.0% (70/172) participants had no bacterial growth, 26.2% (45/172) candida species, (6.4%)11/172 Lactobacilli, 5.8% (10/172) gram negative rods, 1.2% (2/172) Proteus, 0.60% (1/172) Streptococcus agalactiae and 19.2% (33/172) had Staphylococcus aureus. There was no statistically significant difference regarding presence of abnormal vaginal microbiome between the women seeking contraception and those seeking infertility treatment. (OR 2.546, CI:0.775-8.364). Conclusion: No significant differences were found between the vaginal microbial profile of women seeking contraception and those seeking fertility treatment. Candida species were the most prevalent microbe across both groups.
No takes yet. Share an insight, caveat, or question.
Sefogah et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: